HIIFS
BLUE

Harel Insurance Investments & Financial Services’s bluebird bio BLUE Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-77
Closed -$61K – 629
2020
Q2 		$61K Buy
+77
New +$58.1K ﹤0.01% 384
2019
Q1 		– Sell
-54
Closed -$69K – 454
2018
Q4 		$69K Sell
54
-35
-39% -$53.7K ﹤0.01% 268
2018
Q3 		$167K Buy
89
+77
+642% +$159K 0.01% 219
2018
Q2 		$25K Hold
12
– – ﹤0.01% 372
2018
Q1 		$27K Buy
+12
New +$30.5K ﹤0.01% 360

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Harel Insurance Investments & Financial Services's BLUE Position: Q3 2020 in Review

Harel Insurance Investments & Financial Services sold out of bluebird bio (BLUE) in Q3 2020, closing a stake of 77 shares — an estimated $61K sold.

Harel Insurance Investments & Financial Services first reported a position in BLUE in Q1 2018 and held it in 5 quarters. The position peaked at $167K in Q3 2018. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.

  • Harel Insurance Investments & Financial Services reported no remaining bluebird bio position as of Q3 2020 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 77 bluebird bio shares in Q3 2020, an estimated $61K.
  • Harel Insurance Investments & Financial Services first reported a position in bluebird bio in Q1 2018 and held it in 5 quarters.
  • Harel Insurance Investments & Financial Services's bluebird bio position peaked at $167K in Q3 2018.
  • 275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2020, filed 20 Oct 2020.